SCHEMBL6204413

SCHEMBL6204413

O=C1C=NC=Cc2ccccc2N1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
GAA P10253 1/20 0.48
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
P2RX4 Q99571 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
PDGFRA P16234 1/20 0.31
FER P16591 1/20 0.31
LTK P29376 1/20 0.31
CDK8 P49336 1/20 0.31
ACVR1 Q04771 1/20 0.31
LRRK2 Q5S007 1/20 0.31
DYRK1B Q9Y463 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204410 1.00 MAPT (0.48) MAPTGAARAB9ASMN1; SMN2P2RX4
SCHEMBL7440282 0.72 MAPT (0.56) MAPTGAARAB9ASMN1; SMN2P2RX4
SCHEMBL7440281 0.72 MAPT (0.56) MAPTGAARAB9ASMN1; SMN2P2RX4
SCHEMBL4787144 0.69 MAPT (0.50) MAPTGAAMAOAMAOBPDGFRA
SCHEMBL124177 0.69 MAPT (0.50) MAPTGAAMAOAMAOBPDGFRA
SCHEMBL3632795 0.68 GAA (0.44) MAPTGAA
Iminostilbene SCHEMBL29926907 0.67 MAPT (1.00) MAPTGAARAB9ASMN1; SMN2P2RX4
Iminostilbene SCHEMBL75288 0.67 MAPT (1.00) MAPTGAARAB9ASMN1; SMN2P2RX4
SCHEMBL5816758 0.66 MAPT (0.47) MAPTGAARAB9ASMN1; SMN2P2RX4
SCHEMBL5816754 0.66 MAPT (0.47) MAPTGAARAB9ASMN1; SMN2P2RX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497296-A1 1,4 DIAZOCINO 7,8,1-hi INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS Wyeth (US) 2005-01-19 EP disclosed
WO-2003091257-A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS WYETH (US) 2003-11-06 WO disclosed